STXS
STXS
AMEX · Health Care

Stereotaxis Inc

$1.86
+0.02 (+1.09%)
As of Apr 1, 2:36 PM ET ·
Financial Highlights (FY 2026)
Revenue
35.95M
Net Income
-24,025,349
Gross Margin
52.7%
Profit Margin
-66.9%
Rev Growth
+4.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.7% 52.7% 28.9% 28.9%
Operating Margin -69.8% -62.8% 17.9% 17.4%
Profit Margin -66.9% -63.5% 17.6% 14.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 35.95M 34.32M 48.26M 53.66M
Gross Profit 18.96M 18.09M 13.94M 15.50M
Operating Income -25,098,218 -21,559,984 8.66M 9.35M
Net Income -24,025,349 -20,638,364 8.48M 7.97M
Gross Margin 52.7% 52.7% 28.9% 28.9%
Operating Margin -69.8% -62.8% 17.9% 17.4%
Profit Margin -66.9% -63.5% 17.6% 14.9%
Rev Growth +4.8% +4.8% -8.7% +18.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 84.62M 80.81M
Total Equity 87.10M 96.45M
D/E Ratio 0.97 0.84
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -23,853,667 -21,629,267 11.74M 13.85M
Free Cash Flow 4.58M 4.02M